Saturday 7 November 2026
Export NUVB’s income statement to Excel — free account
Nuvation Bio Inc.
NUVB Healthcare Biotechnology
Nuvation Bio Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.9 million, up 699.0% from fiscal 2024.
- Revenue
- +242.6%
- EPS
- +25.6%
- Free cash flow
- +34.1%
- Total debt
- +441.5%
Quarter to September 2026, against a year earlier
4.17
0.02
−0.48%
Follow NUVB
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(53.18%) | (39.51%) | (47.81%) | (49.09%) | |
| (36.04%) | (26.48%) | (21.53%) | (19.70%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(41.77%) | (28.48%) | (23.40%) | (21.30%) | |
Average Days of Receivables |
112.35 | 66.30 | 68.13 | 72.77 | |
Free Cash Flow per Share |
(0.51) | (0.36) | (0.35) | (0.31) | |
Free Cash Flow |
(173.78) | (126.06) | (120.92) | (108.17) | |
Capital Expenditures |
(0.35) | (0.33) | (0.40) | (1.98) | |
| Other line items | |||||
Cash ROIC |
(19.57%) | (13.91%) | (10.39%) | (9.19%) | |
Accounts Receivable Turnover |
3.53 | 9.10 | 8.85 | 7.46 | |
Accounts Payable Turnover |
1.18 | 0.80 | 1.16 | 2.31 | |
Inventory Turnover |
0.00 | 1.66 | 1.96 | 2.72 | |
Average Days of Payables |
372.11 | 620.60 | 219.64 | 120.26 | |
Days of Inventory on Hand |
447.95 | 438.28 | 361.57 | 195.26 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
182.99% | 87.77% | 75.84% | 65.77% | |
Selling, General and Administrative Expense of Revenue |
240.95% | 107.99% | 93.34% | 81.19% | |
Share Based Compensation of Revenue |
57.06% | 25.92% | 20.90% | 18.61% | |
Interest Coverage |
(15.57) | (7.38) | (5.16) | (4.70) | |
Operating CF/Net income |
0.85 | 0.86 | 0.80 | 0.78 | |
Depreciation/Fixed assets |
4.26 | 5.51 | 4.84 | 1.68 | |
Capex/Depreciation |
(0.15) | (0.11) | (0.12) | (0.53) | |
Revenue per Share |
0.18 | 0.41 | 0.49 | 0.57 | |
Operating CF per Share |
(0.51) | (0.36) | (0.35) | (0.30) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | |
Capex to Sales |
0.01 | 0.00 | 0.00 | 0.01 |
Columns are period end dates · fundamentals updated 6 Nov 2026